Search Result "refractory Hodgkin Lymphoma"

mTOR as a Target of Everolimus in Refractory/Relapsed Hodgkin Lymphoma

Journal: Current Medicinal Chemistry
Volume: 19 Issue: 7 Year: 2012 Page: 945-954
Author(s): A. Guarini, C. Minoia, M. Giannoccaro, A. Rana, A. Iacobazzi, A. Lapietra, A. Raimondi, N. Silvestris, C. D. Gadaleta, G. Ranieri

Antibody-Targeted Immunotherapy for Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 1 Issue: 4 Year: 2000 Page: 303-312
Author(s): Christine A. White, Judy R. Berlfein, Antonio J. Grillo-Lopez

Research Article

Evaluation of the Reliability of Interim PET/CT in the Hodgkin Lymphoma

Journal: Current Medical Imaging
Volume: 16 Issue: 1 Year: 2020 Page: 59-64
Author(s): Rafet Eren,Cihan Gündoğan,Ceyda Aslan,Alper Koç,Mehmet Hilmi Doğu,Şermin Altındal,Osman Yokuş,Elif Suyanı,Tevfik Fikret Çermik

Rituxan® Immunotherapy and Zevalin® Radioimmunotherapy in the Treatment of Non-Hodgkins Lymphoma

Journal: Current Pharmaceutical Biotechnology
Volume: 4 Issue: 4 Year: 2003 Page: 221-238
Author(s): Christine A. White

Perspective

Pirtobrutinib: First Non-covalent Tyrosine Kinase Inhibitor forTreating Relapsed or Refractory Mantle Cell Lymphoma in Adults

Journal: Current Medicinal Chemistry
Volume: 31 Issue: 30 Year: 2024 Page: 4757-4762
Author(s): Surya K. De

Research Article

Pharmacokinetic and Pharmacodynamic Relationship of Blinatumomab in Patients with Non-Hodgkin Lymphoma

Journal: Current Clinical Pharmacology
Volume: 13 Issue: 1 Year: 2018 Page: 55-64
Author(s): Youssef Hijazi,Matthias Klinger,Andrea Kratzer,Benjamin Wu,Patrick A. Baeuerle,Peter Kufer,Andreas Wolf,Dirk Nagorsen,Min Zhu

Non-Hodgkins Lymphoma: Review of Conventional Treatments

Journal: Current Pharmaceutical Biotechnology
Volume: 2 Issue: 4 Year: 2001 Page: 279-291
Author(s): P. Multani, C.A. White, A. Grillo-Lopez

Review Article

Mechanism and Treatment of Rituximab Resistance in Diffuse Large Bcell Lymphoma

Journal: Current Cancer Drug Targets
Volume: 19 Issue: 9 Year: 2019 Page: 681-687
Author(s): Linqing Zou,Guoqi Song,Siyu Gu,Lingling Kong,Shiqi Sun,Li Yang,William C. Cho

Biodistribution and Dosimetry of 177Lu-tetulomab, a New Radioimmunoconjugate for Treatment of Non-Hodgkin Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 6 Issue: 1 Year: 2013 Page: 20-27
Author(s): Ada H. V. Repetto-Llamazares, Roy H. Larsen, Camilla Mollatt, Michael Lassmann, Jostein Dahle

Research Article

Preliminary Experience with Yttrium-90-labelled Rituximab (Chimeric Anti CD-20 Antibody) in Patients with Relapsed and Refractory B Cell Non-Hodgkins Lymphoma

Journal: Current Radiopharmaceuticals
Volume: 9 Issue: 2 Year: 2016 Page: 160-168
Author(s): Parul Thakral,Suhas Singla,Atul Vashist,Madhav P. Yadav,Santosh K. Gupta,Jaya S. Tyagi,Atul Sharma,Chandra S. Bal,Snehlata,Arun Malhotra

Previous   Next

Go To   Results 1 - 1 of 788

Apply Filters

Volume Years
Article Type
Publication Title
Subject Title

Content Type


© 2025 Bentham Science Publishers | Privacy Policy